The largest database of trusted experimental protocols

Venetoclax

Manufactured by Targetmol

Venetoclax is a small-molecule inhibitor of the anti-apoptotic protein BCL-2, which is involved in regulating cell survival and death. It is used in the research and development of cancer therapeutics.

Automatically generated - may contain errors

2 protocols using venetoclax

1

Expanding and Treating DNT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNT expansions were performed as previously described.11 (link) Briefly, CD4+ and CD8+ cell-depleted healthy donor–derived PBMCs were cultured on anti-CD3 antibody-coated plates (OKT3; BioLegend) for 3 days in AIM-V (Thermo Fisher Scientific) with 250 IU/mL of interleukin-2 (IL-2) (Proleukin; Novartis Pharmaceuticals); soluble anti-CD3 antibody and IL-2 were added to the cultures every 2 to 4 days. The purity of DNTs was assessed by staining cells with fluorochrome-conjugated anti-human CD3, -CD4, -CD8, and -CD56 antibodies and flow cytometry analysis. DNTs were used between days 10 and 20 of culture. For venetoclax treatment, 25 to 400 nM venetoclax (ABT-199; TargetMol) was added to DNT culture 4 hours to 3 days before use. DNTs were washed twice with phosphate-buffered saline and counted before use for each experiment.
+ Open protocol
+ Expand
2

Venetoclax and Fedratinib Combination Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venetoclax (1 mL*10 mM in DMSO) and powdered compound were purchased from TargetMol. Fedratinib (1 mL*10 mM in DMSO) was purchased from Selleckchem and powdered was purchased from MedChemExpress. All concentrations for in vitro studies were made at 2x or 4x for combination studies and diluted in RPMI-10 for plating assays. Cells were treated with a range of doses ranging from 1nM to 10uM.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!